GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » EBITDA Margin %

Greenfern Industries (NZSE:GFI) EBITDA Margin % : -331.40% (As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Greenfern Industries's EBITDA for the six months ended in Mar. 2023 was NZ$-1.83 Mil. Greenfern Industries's Revenue for the six months ended in Mar. 2023 was NZ$0.55 Mil. Therefore, Greenfern Industries's EBITDA margin for the quarter that ended in Mar. 2023 was -331.40%.


Greenfern Industries EBITDA Margin % Historical Data

The historical data trend for Greenfern Industries's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenfern Industries EBITDA Margin % Chart

Greenfern Industries Annual Data
Trend Mar22 Mar23
EBITDA Margin %
-962.44 -331.40

Greenfern Industries Semi-Annual Data
Mar22 Mar23
EBITDA Margin % -962.44 -331.40

Competitive Comparison of Greenfern Industries's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Greenfern Industries's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenfern Industries's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenfern Industries's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Greenfern Industries's EBITDA Margin % falls into.



Greenfern Industries EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Greenfern Industries's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-1.826/0.551
=-331.40 %

Greenfern Industries's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-1.826/0.551
=-331.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenfern Industries  (NZSE:GFI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Greenfern Industries EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenfern Industries (NZSE:GFI) Business Description

Traded in Other Exchanges
N/A
Address
115 Queen Street, Level 8, General Capital House, Auckland, NTL, NZL, 1040
Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.